Call for eye health professionals to participate in charity survey

Article

Fight for Sight is calling for eye health professionals to participate in the Sight Loss and Vision Survey to aid the future development of eye research.

Fight for Sight is calling for eye health professionals to participate in the Sight Loss and Vision Survey to aid the future development of eye research.

The NIHR Biomedical Research Centre for Ophthalmology, the Royal College of Ophthalmologists, the RNIB and UK Vision strategy are working together to launch the Sight Loss and Vision Survey.

Anyone involved in the ophthalmic field will be able to complete the survey and put forward any questions about further eye research. The results of the survey will be used to prioritize the needs of people with sight loss, their carers and eye health professionals.

Chief executive of Fight for Sight, Michele Acton, said, "With limited resources available, it is crucial that eye health professionals have their say in prioritizing medical research into the prevention, diagnosis and treatment of eye disease. For the first time, the Sight Loss and Vision Survey will allow eye health specialists to do just that. We hope that as many professionals as possible working in the field of eye health all over the UK take part and tell us which questions they want research to answer.”

For those who want to take part in the survey please visit www.sightlosspsp.org.uk Large print and Braille versions are available on request.,/p>

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.